tiprankstipranks
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Germany Market
9Y4
Ryvu Therapeutics SA
RESEARCH TOOLSreports

Ryvu Therapeutics SA (9Y4) Financial Statements

1 Followers

Ryvu Therapeutics SA Financial Overview

Ryvu Therapeutics SA's market cap is currently €128.03M. The company's EPS TTM is €-0.178947628; its P/E ratio is -6.19; Ryvu Therapeutics SA is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuezł 62.25Mzł 77.97Mzł 46.86Mzł 38.80Mzł 11.19M
Gross Profitzł -117.03Mzł 58.39Mzł 29.31Mzł 21.40Mzł -2.54M
Operating Incomezł -122.15Mzł -122.10Mzł -100.95Mzł -78.42Mzł -103.78M
EBITDAzł -112.71Mzł -96.83Mzł -81.04Mzł -65.21Mzł -65.96M
Net Incomezł -101.23Mzł -111.44Mzł -92.11Mzł -83.78Mzł -79.08M
Balance Sheet
Cash & Short-Term Investmentszł 107.68Mzł 225.40Mzł 233.67Mzł 102.44Mzł 88.23M
Total Assetszł 224.44Mzł 378.78Mzł 403.20Mzł 474.98Mzł 228.81M
Total Debtzł 71.72Mzł 75.51Mzł 906.00Kzł 2.77Mzł 5.07M
Net Debtzł 12.11Mzł -84.56Mzł -57.03Mzł -99.15Mzł -78.17M
Total Liabilitieszł 153.69Mzł 234.89Mzł 143.61Mzł 131.59Mzł 59.39M
Stockholders' Equityzł 53.83Mzł 143.88Mzł 259.59Mzł 343.39Mzł 161.30M
Cash Flow
Free Cash Flowzł -117.75Mzł -135.38Mzł -88.11Mzł 12.03Mzł -69.85M
Operating Cash Flowzł -110.28Mzł -129.48Mzł -84.55Mzł 21.32Mzł -57.87M
Investing Cash Flowzł 13.35Mzł 137.16Mzł -195.54Mzł 690.00Kzł 8.06M
Financing Cash Flowzł -3.05Mzł 94.21Mzł 240.83Mzł -2.46Mzł -3.17M
Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History

Income Statement >

Ryvu Therapeutics SA Debt to Assets

Balance Sheet >

Ryvu Therapeutics SA Cash Flow

Cash Flow >

Ryvu Therapeutics SA Forecast EPS vs Actual EPS

Earnings >